Media reports on COVID-19 vaccine data of private hospitals 'not accurate', says Centre

-

Private hospitals have been able to procure 1.29 crore COVID-19 vaccine doses in May, out of which they have administered 22 lakh doses, the Union Health Ministry said on Friday adding that comparing data from 16 January with a policy initiated on 1 May is "unfair and misleading".

The ministry referred to a few media reports that mentioned "25 percent doses (have been) allocated to private hospitals, but they account for only 7.5 per cent of total jabs". It said the reports are "not accurate and do not match with the available data".

"They deliberately compare two non-comparable data points to suggest a mismatch in allocation and administration of doses in the private sector," the ministry said in a statement.

In May, 2021, since the liberalised policy was introduced, a total of 7.4 crore doses were available for vaccination.

"Out of these, 1.85 crore doses were earmarked for procurement by private hospitals. The private hospitals have been able to procure 1.29 crore doses in the month of May, 2021, out of which they have administered 22 lakh doses. These numbers translate into over 17 percent," the ministry said.

It said that most of the supplies to private hospitals have materialized in the second half of May. The data shows an increasing trend of vaccines administered by private hospitals as the vaccine supply picked up by mid-May, the statement said.

The government of India, in close partnership with all the states and UTs, is running one of the largest COVID-19 vaccination drives in the world since January 16.

A 'Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy' was adopted on May 1 which is guiding the ongoing Phase III of the drive.

Under the strategy, every month 50 per cent of the total Central Drugs Laboratory (CDL) cleared vaccine doses of any manufacturer would be procured by Government of India.

It would continue to make these doses available to the states and UTs totally free of cost as was being done earlier. The remaining 50 per cent doses are available for direct procurement by State/UT governments and private hospitals.

This strategy aims at incentivising the vaccine manufacturers to ramp up production and also attract new manufacturers. This will augment production resulting in wider availability of vaccines resulting in flexibility in pricing, procurement and administration of vaccines, ultimately resulting in improved coverage of vaccination.

This was also done with a view to improving accessibility of services across the country, the statement said.

The Union Ministry of Health is working closely with all states and UTs to make the COVID-19 vaccination drive a success.

In this regard, regular communication is being held all states and UTs to encourage private hospitals by placing orders with manufacturers. This has already been communicated to all states and UTs to leverage their network of private hospitals and trained staff, and contribute to the success of the vaccination drive, the statement said.



from Firstpost India Latest News https://ift.tt/3pntHfD
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more